ALGSNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Aligos Therapeutics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$4.84−0.02 (-0.41%)
Close on Oct 19, 2026
- Market cap
- $50.49M
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Aligos Therapeutics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Sep 10, 2026 | Sep 15, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 6, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 6, 2026 | Aug 6, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 25, 2026 | Jun 26, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 7, 2026 | SEC EDGAR |
| Current report | 8-K | May 7, 2026 | May 7, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 25, 2026 | Apr 29, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 16, 2026 | Apr 21, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 14, 2026 | Apr 14, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 5, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 5, 2026 | Mar 5, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 29, 2026 | Feb 4, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 6, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 6, 2025 | Nov 6, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 6, 2025 | Aug 6, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 6, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 25, 2025 | Jun 26, 2025 | SEC EDGAR |
| Current report | 8-K | May 6, 2025 | May 6, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 6, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 25, 2025 | Apr 28, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 10, 2025 | Mar 10, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Mar 10, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 11, 2025 | Feb 12, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 30, 2025 | Feb 3, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 6, 2024 | Nov 6, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 6, 2024 | SEC EDGAR |
| Current report | 8-K | Sep 3, 2024 | Sep 5, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 14, 2024 | Aug 19, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 7, 2024 | Aug 8, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 6, 2024 | Aug 6, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 6, 2024 | SEC EDGAR |
| Current report | 8-K | Jun 27, 2024 | Jun 28, 2024 | SEC EDGAR |
| Current report | 8-K | May 29, 2024 | May 31, 2024 | SEC EDGAR |
| Current report | 8-K | May 21, 2024 | May 22, 2024 | SEC EDGAR |
| Current report | 8-K | May 9, 2024 | May 15, 2024 | SEC EDGAR |
| Current report | 8-K | May 7, 2024 | May 7, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2024 | May 7, 2024 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 27, 2024 | Apr 29, 2024 | SEC EDGAR |
| Current report | 8-K | Mar 12, 2024 | Mar 12, 2024 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2023 | Mar 12, 2024 | SEC EDGAR |